Tardive Dyskinesia, Neuroleptic Malignant Syndrome, Heart Attack, Suicide, Diabetes
Geodon®(ziprasidone) has been linked to serious and potentially permanent side effects or death. One of the class of atypical antipsychotic drugs, Geodon® is approved by the FDA to treat patients with specific aspects of schizophrenia and bipolar disorder. Geodon®is manufactured by Pfizer; the generic version, ziprasidone, is made by other manufacturers.
Sheller, P.C. attorneys are investigating cases involving these serious and potentially fatal side effects
- Tardive Dyskinesia: an involuntary movement syndrome involving incontrollable muscle movement of the arms, legs, tongue, face, mouth, or jaw. Some of the specific uncontrollable movements in the face may include tongue sticking out, puffing of cheeks, mouth puckering, and chewing movements.
- Neuroleptic Malignant Syndrome (NMS): a possibly fatal syndrome, with symptoms including stiff muscles, sweating, fever, confusion, abnormal thinking, and fast or irregular heartbeat
- Increased mortality in the elderly with dementia-related psychosis
- Increased risk of sudden death from heart attack (cardiac arrhythmias and other cardiac causes)
- Diabetes, hyperglycemia, and other blood sugar side effects, especially in children and the elderly
Sheller, P.C. attorneys represented one of the whistleblowers in the Pfizer settlement, a drug marketing representative who alerted the authorities that the drug manufacturer continued to market a drug illegally, ignoring a 2005 FDA warning.
As a result of these marketing practices, some patients who were prescribed Geodon® may have suffered the serious and potentially permanent side effects listed above.
The FDA did not initially approved the drug that came to be called Geodon®
Geodon® was approved in the United States in February of 2001 for the treatment of schizophrenia and in 2004 for acute bipolar mania. It is an atypical antipsychotic medicine similar to Risperdal®, Seroquel® and Zyprexa®. The FDA originally denied approval of the drug when Pfizer submitted it for approval under another name three years earlier under a different name due to concerns over safety data including “potentially fatal” heart problems. Pfizer’s drug was eventually approved in 2001 under the name Geodon® under the stipulation that the labeling indicate approval only for specific schizophrenia-related conditions at that time.
The attorneys of Sheller, P.C. are currently investigating these cases
If you or someone in your family has experienced or been diagnosed with any of these side effects while taking Geodon®or any other antipsychotic medication such as Risperdal®, Seroquel® or Zyprexa®, contact us now to learn your rights and protect your health.